1. Hong J, Windmeijer F, Novick D, Haro JM, Brown J. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:835-841. PMID:
19351551.
2. Davis JM. Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry 1975;132:1237-1245. PMID:
914.
3. Hogarty GE. Prevention of relapse in chronic schizophrenic patients. J Clin Psychiatry 1993;54(Suppl):18-23. PMID:
8097193.
4. Hogarty GE, Schooler NR, Ulrich R, Mussare F, Ferro P, Herron E. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Arch Gen Psychiatry 1979;36:1283-1294. PMID:
227340.
5. Hogarty GE, Ulrich RF. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment. J Psychiatr Res 1998;32:243-250. PMID:
9793877.
6. Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997;54:453-463. PMID:
9152099.
7. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-247. PMID:
10078501.
8. Chien IC, Chou YJ, Lin CH, Bih SH, Chang HJ, Chou P. Use of health care services and costs of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 2004;55:1427-1430. PMID:
15572572.
9. Eldon Taylor C, Lopiccolo CJ, Eisdorfer C, Clemence C. Best practices: reducing rehospitalization with telephonic targeted care management in a managed health care plan. Psychiatr Serv 2005;56:652-654. PMID:
15939940.
10. Appleby L, Desai PN, Luchins DJ, Gibbons RD, Hedeker DR. Length of stay and recidivism in schizophrenia: a study of public psychiatric hospital patients. Am J Psychiatry 1993;150:72-76. PMID:
8417584.
11. Appleby L, Luchins DJ, Desai PN, Gibbons RD, Janicak PG, Marks R. Length of inpatient stay and recidivism among patients with schizophrenia. Psychiatr Serv 1996;47:985-990. PMID:
8875666.
12. Saarento O, Kastrup M, Lonnerberg O, Gostas G, Muus S, Sandlund M, et al. The Nordic Comparative Study on Sectorized Psychiatry: patients who use only psychiatric in-patient care in comprehensive community-based services--a 1-year follow-up study. Acta Psychiatr Scand 1998;98:98-104. PMID:
9718234.
13. Dincin J, Wasmer D, Witheridge TF, Sobeck L, Cook J, Razzano L. Impact of assertive community treatment on the use of state hospital inpatient bed-days. Hosp Community Psychiatry 1993;44:833-838. PMID:
8225294.
14. Pfeiffer SI, O'Malley DS, Shott S. Factors associated with the outcome of adults treated in psychiatric hospitals: a synthesis of findings. Psychiatr Serv 1996;47:263-269. PMID:
8820549.
15. Ucok A, Polat A, Cakir S, Genc A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur Arch Psychiatry Clin Neurosci 2006;256:37-43. PMID:
16010602.
16. Jung SH, Kim WH, Choi HJ, Kang MH, Lee JS, Bae JN, et al. Factors affecting treatment discontinuation and treatment outcome in patients with schizophrenia in Korea: 10-year follow-up study. Psychiatry Investig 2011;8:22-29.
17. Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 2010;176:109-113. PMID:
20185182.
18. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223. PMID:
16172203.
19. Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 2008;371:1085-1097. PMID:
18374841.
20. Wang HR, Woo YS, Jung YE, Song HR, Jun TY, Bahk WM. Predictors of continuity of care after inpatient discharge of patients with schizophrenia: a retrospective chart review study in a university hospital. Korean J Psychopharmacol 2010;21:195-201.
21. Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA, et al. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry 2008;69:106-113. PMID:
18312044.
22. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, et al. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006;83:53-63. PMID:
16529910.
23. Robinson DG, Woerner MG, Alvir JM, Bilder RM, Hinrichsen GA, Lieberman JA. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res 2002;57:209-219. PMID:
12223252.
24. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002;106:286-290. PMID:
12225495.
25. Verdoux H, Lengronne J, Liraud F, Gonzales B, Assens F, Abalan F, et al. Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2000;102:203-210. PMID:
11008856.
26. Mojtabai R, Lavelle J, Gibson PJ, Sohler NL, Craig TJ, Carlson GA, et al. Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatr Serv 2002;53:337-339. PMID:
11875230.
27. Mutsatsa SH, Joyce EM, Hutton SB, Webb E, Gibbins H, Paul S, et al. Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand 2003;108:439-446. PMID:
14616225.
28. Boden R, Brandt L, Kieler H, Andersen M, Reutfors J. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Res 2011;133:36-41. PMID:
21982098.
29. Green JH. Frequent rehospitalization and noncompliance with treatment. Hosp Community Psychiatry 1988;39:963-966. PMID:
3215645.
30. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997;23:637-651. PMID:
9366000.
31. Lin HC, Tian WH, Chen CS, Liu TC, Tsai SY, Lee HC. The association between readmission rates and length of stay for schizophrenia: a 3-year population-based study. Schizophr Res 2006;83:211-214. PMID:
16504482.
32. Lyons JS, O'Mahoney MT, Miller SI, Neme J, Kabat J, Miller F. Predicting readmission to the psychiatric hospital in a managed care environment: implications for quality indicators. Am J Psychiatry 1997;154:337-340. PMID:
9054780.
33. Olfson M, Mechanic D, Boyer CA, Hansell S, Walkup J, Weiden PJ. Assessing clinical predictions of early rehospitalization in schizophrenia. J Nerv Ment Dis 1999;187:721-729. PMID:
10665466.
34. Swett C. Symptom severity and number of previous psychiatric admissions as predictors of readmission. Psychiatr Serv 1995;46:482-485. PMID:
7627673.
35. Compton MT, Rudisch BE, Craw J, Thompson T, Owens DA. Predictors of missed first appointments at community mental health centers after psychiatric hospitalization. Psychiatr Serv 2006;57:531-537. PMID:
16603749.
36. Nelson EA, Maruish ME, Axler JL. Effects of discharge planning and compliance with outpatient appointments on readmission rates. Psychiatr Serv 2000;51:885-889. PMID:
10875952.
37. Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011;168:603-609. PMID:
21362741.
38. Lin HC, Lee HC. The association between timely outpatient visits and the likelihood of rehospitalization for schizophrenia patients. Am J Orthopsychiatry 2008;78:494-497. PMID:
19123771.
39. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization; 1992.
40. Grinshpoon A, Lerner Y, Hornik-Lurie T, Zilber N, Ponizovsky AM. Post-discharge contact with mental health clinics and psychiatric readmission: a 6-month follow-up study. Isr J Psychiatry Relat Sci 2011;48:262-267. PMID:
22572089.
41. Olfson M, Mechanic D, Boyer CA, Hansell S. Linking inpatients with schizophrenia to outpatient care. Psychiatr Serv 1998;49:911-917. PMID:
9661225.
42. Boyer CA, McAlpine DD, Pottick KJ, Olfson M. Identifying risk factors and key strategies in linkage to outpatient psychiatric care. Am J Psychiatry 2000;157:1592-1598. PMID:
11007712.
43. Norman RM, Malla AK, Cortese L, Diaz F. Aspects of dysphoria and symptoms of schizophrenia. Psychol Med 1998;28:1433-1441. PMID:
9854284.
44. Norman RM, Malla AK. Dysphoric mood and symptomatology in schizophrenia. Psychol Med 1991;21:897-903. PMID:
1780402.
45. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Casey E. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 1988;145:1532-1537. PMID:
3057924.
46. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 2001;51:171-180. PMID:
11518637.
47. Geddes J, Mercer G, Frith CD, MacMillan F, Owens DG, Johnstone EC. Prediction of outcome following a first episode of schizophrenia. A follow-up study of Northwick Park first episode study subjects. Br J Psychiatry 1994;165:664-668. PMID:
7866682.
48. Sands JR, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999;25:157-171. PMID:
10098919.
49. McGlashan TH, Carpenter WT Jr. An investigation of the postpsychotic depressive syndrome. Am J Psychiatry 1976;133:14-19. PMID:
1247119.
50. Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophr Bull 2009;35:696-703. PMID:
19491314.
51. Park KG, Won SH, Kim SH, Kim HD, Kang BJ. The factors affecting follow-up treatment of schizophrenia after discharge. J Korean Soc Biol Ther Psychiatry 1998;4:210-222.
52. Doering S, Muller E, Kopcke W, Pietzcker A, Gaebel W, Linden M, et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull 1998;24:87-98. PMID:
9502548.
53. Al-Zakwani IS, Barron JJ, Bullano MF, Arcona S, Drury CJ, Cockerham TR. Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications. Curr Med Res Opin 2003;19:619-626. PMID:
14606985.
54. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry 2002;159:103-108. PMID:
11772697.
55. Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. J Clin Psychiatry 2006;67:222-232. PMID:
16566617.
56. Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang RH. Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics. Psychiatry Res 2006;144:177-189. PMID:
17010448.
57. Tollefson GD, Beasley CM Jr, Tamura RN, Tran PV, Potvin JH. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248-1254. PMID:
9286184.
58. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796. PMID:
3046553.
59. Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J. Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70-76. PMID:
9919323.
60. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716-719. PMID:
10366172.
61. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Seroquel Study Group. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry 1997;54:549-557. PMID:
9193196.
62. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835. PMID:
7514366.
63. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51:216-222. PMID:
10655006.
64. Cabeza IG, Amador MS, Lopez CA, Gonzalez de Chavez M. Subjective response to antipsychotics in schizophrenic patients: clinical implications and related factors. Schizophr Res 2000;41:349-355. PMID:
10708344.
65. Olfson M, Marcus SC, Doshi JA. Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis. J Clin Psychiatry 2010;71:831-838. PMID:
20441730.
66. Rosenblatt A, Mayer JE. The recidivism of mental patients: a review of past studies. Am J Orthopsychiatry 1974;44:697-706. PMID:
4611230.
67. Health Insurance Review & Assessment Service (HIRA). IT & Other activities, Part III. Seoul, Korea: HIRA; 2011.
68. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009;374:620-627. PMID:
19595447.
69. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 2006;63:1358-1367. PMID:
17146010.